MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/antib14030066

Медицинская библиотека · Antibodies (Basel, Switzerland) · 2025

Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre.

Spałek Maciej Marek, Jałowska Magdalena, Welc Natalia, Bowszyc-Dmochowska Monika, Hashimoto Takashi, Gornowicz-Porowska Justyna, Dmochowski Marian

СтатьяПеревод в очереди

Аннотация

Background/

Objectives

Anti-p200 pemphigoid is a rare and likely underdiagnosed autoimmune blistering disorder. Laminin γ1 and laminin β4 have been implicated as potential target antigens in its pathogenesis. Recently, a novel indirect immunofluorescence assay targeting anti-laminin β4 antibodies has been developed, demonstrating high sensitivity and specificity, and offering a valuable tool for improved diagnosis.

Methods

Of the 451 patients, 21 were selected for further laboratory analysis based on medical records. Sera from 10 patients, which showed a positive direct immunofluorescence (DIF) result and negative results in multiplex enzyme-linked immunosorbent assays (ELISAs) and/or mosaic six-parameter indirect immunofluorescence (IIF) for various autoimmune bullous diseases, were tested for the presence of anti-laminin β4 antibodies. Additionally, sera from 11 patients with positive DIF and positive ELISA for antibodies against BP180 and/or BP230 were analyzed.

Results

Among the 10 patients with positive DIF and negative ELISA and/or mosaic six-parameter IIF, 6 sera were positive for anti-laminin β4 antibodies. These patients presented with atypical clinical features. In contrast, all 11 sera from patients with both positive DIF and positive ELISA for BP180 and/or BP230 were negative for anti-laminin β4 antibodies.

Conclusions

In patients with a positive DIF result but negative ELISA and/or mosaic six-parameter IIF findings, testing for anti-laminin β4 antibodies should be considered. Furthermore, in cases presenting with atypical clinical features-such as acral distribution of lesions, intense pruritus, or erythematous-edematous plaques-the possibility of anti-p200 pemphigoid should be included in the differential diagnosis.

Для цитирования: Spałek Maciej Marek, Jałowska Magdalena, Welc Natalia, Bowszyc-Dmochowska Monika, Hashimoto Takashi, Gornowicz-Porowska Justyna, Dmochowski Marian. Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre.. Antibodies (Basel, Switzerland). 2025. DOI: 10.3390/antib14030066.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.